----
Q2 FY2026 EarningsQ2 FY26 revenue of $271.0M beat consensus of $268.9M, while GAAP EPS of -$2.10 missed the expected $0.11 significantly due to a $403.3M non-cash loss from the Harvest deconsolidation. Excluding this one-time transaction, operational performance remained resilient with a gross margin of 59.9% vs. the 61.7% mean estimate. Cash from operations was strong at $108.8M for the first half of the year, outperforming expectations, despite a 10% YoY revenue decline primarily driven by the strategic deconsolidation and pricing pressures in mature markets.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Trulieve Cannabis(TRLV) the Revenue is 271 M (-10.29%), Beat estimate;the EBIT is -370.5 M (-710.4%), Miss estimate;the EPS is -2.1 (-2900%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.27B10.29%
0.27B11.00%
+0.00B0.71%
EBITMiss expectations
-0.37B710.38%
0.04B28.42%
-0.41B681.96%
EPSMiss expectations
-2.12900.00%
0.1067252.39%
-2.20673,152.39%
Upcoming earnings report - Q3 FY2026
Available dateNov 5, 2026
Estimate Revenue$221.63 M
Estimate EBIT$30.94 M
Estimate EPS$0.0825
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
